The U.S. Center for Disease Control said 50 people have now died, including the first first death in Ohio, in connection with a fungal meningitis outbreak tied to tainted steroid injections produced at Framingham-based New England Compounding Center.

Michigan has recorded its 14th death. Tennessee and Michigan now both have 14 deaths.

More than 700 people across America after being injected with a steroid pain medication produced at NECC in Framingham developed fungal meningitis, suffered strokes and were diagnosed with spinal and peripheral joint infections.

Sunday night, 60 Minutes aired an investigation into the Waverly Street specialty pharmacy, that has since closed, surrendered its license, is being criminally investigated and faces scores of civil lawsuits.

View the 60 Minutes report here.

The embattled specialty pharmacy filed paperwork with the U.S. Bankruptcy Court in Boston listing assets of $1.259 million and liabilities of $885,514.

According to court documents, the family members, who served as the New England Compounding Center's directors paid themselves more than $16 million with the largest payout to the the specialty pharmacy's majority shareholder, Carla Conigliaro - $8.7 million. Barry Cadden, the company's chief pharmacist, received about $3.2 million in 2012, filings show.

A federal judge has ruled any criminal case against a Framingham specialty pharmacy New England Compounding Center (NECC) would have priority over the numerous civil suits.

New England Compounding Center (NECC) recalled more than 17,000 steroids in September indicating they may contain a fungus. Later, NECC recalled every product made and laid off all employees.

Later, CDC and FDA officials confirmed a fungus was found in those recalled steroids and recently, fungus and bacteria were found in other NECC products.

The FDA released a list of customers, who received products from NECC in Framingham on or after May 21.

***

Click here to find all of Framingham Patch’s coverage of NECC and the meningitis outbreak.